Chinese Pharmaceutical Industry Competes for Vaccine Market Share

Chinese Pharmaceutical Industry Competes for Vaccine Market Share

China’s National Medical Products Administration has announced that two Chinese pharmaceutical companies, Walvax Biotechnology and Innovax, have been approved to start selling their own version of drugs previously available only through global pharmaceutical giants Pfizer, Merck and GlaxoSmithKline.1 Cecolin, developed by Innovax, will compete in the Human Papilloma Virus (HPV) arena against Merck’s Gardasil and […]

Tamiflu on Track to Be an Over-The-Counter Drug

Tamiflu on Track to Be an Over-The-Counter Drug

In July 2019, drug and French vaccine manufacturer Sanofi signed a deal with Roche Pharmaceuticals to obtain exclusive over-the-counter (OTC) rights for Tamiflu (oseltamivir), an antiviral drug licensed for the treatment of influenza infections. Genentech, a member of the Roche Group, currently sells Tamiflu in the United States only for prescription use.1 Tamiflu is a […]

Vaccine Market Valued at $93 Billion by 2026

Vaccine Market Valued at $93 Billion by 2026

A recent report by Fortune Business Insights projects the value of the world market for vaccines to reach $93.08 billion by 2026, with a Compound Annual Growth Rate (CAGR) of 10.7 percent during the forecast period.1 One of the main drivers of the vaccine market is the need for greater supplies of vaccines, given stricter government […]

GlaxoSmithKline Partners with Viome to Develop New Vaccines

GlaxoSmithKline Partners with Viome to Develop New Vaccines

Vaccine manufacturer GlaxoSmithKline (GSK) of the United Kingdom has partnered with Viome, a gut microbiome test company in Seattle, Washington to better understand bacteria that live in the digestive tract and the role they play in the body’s immune system response.1 According to Emmanuel Hanon, senior vice president for research and development at GSK Vaccines, […]

Novartis Manipulated Data in FDA Biologics License Application

Novartis Manipulated Data in FDA Biologics License Application

On Aug. 6, 2019, the U.S. Food and Drug Administration (FDA) issued a statement saying that Swiss pharmaceutical company Novartis AG submitted a biologics license application (BLA) for the spinal muscular atrophy (SMA) gene therapy Zolgensma (onasemnogene abeparvovec-xioi) with manipulated data and failed to inform regulators until June 28, 2019—more than a month after the […]

Pfizer Fined Again for Violating Drug Laws

Pfizer Fined Again for Violating Drug Laws

Colombia’s national regulatory agency, the Superintendency of Industry and Commerce (SIC), has fined pharmaceutical company Pfizer $25,000 for allegedly inflating the price of several prescription drugs it sold in that country.1 2 On July 31, 2019, the agency stated: The decision was taken after verifying information related to PFIZER SAS’ commercial operations between July and December […]

Johnson & Johnson Fined $572 Million for “Greed” in Fueling the Opioid Crisis

Johnson & Johnson Fined $572 Million for “Greed” in Fueling the Opioid Crisis

In a lawsuit filed by the state of Oklahoma against Johnson & Johnson, Inc., Purdue Pharma LP and Teva Pharmaceutical Industries Ltd., the pharmaceutical giant Johnson & Johnson and its subsidiaries were ordered on Aug. 26, 2019 to pay $572 million in penalties for helping to fuel the opioid crisis in Oklahoma.1 Before the trial […]

Google Joins the Pharmaceutical Industry

Google Joins the Pharmaceutical Industry

Story Highlights Google, the world’s most widely used internet search engine, restructured itself to give semi-independence to its many subsidiary organizations under a new umbrella entity called Alphabet. Two of the divisions are focused on the business of medicine and operate in partnership with some of the world’s most powerful pharmaceutical companies that develop and […]

MMR Vaccine Sales Boost Merck’s 2019 Revenues

MMR Vaccine Sales Boost Merck’s 2019 Revenues

After the Centers for Disease Control and Prevention (CDC) publicized measles outbreaks in several states beginning in January 2019, on May 1 Merck & Co. announced that it had increased production of its live attenuated (weakened) virus MMR (measles, mumps, rubella) vaccine in response to an increasing demand for the product in the United States. […]

Former FDA Commissioner Gottlieb Joins Pfizer

Former FDA Commissioner Gottlieb Joins Pfizer

Former Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD has joined the board of directors of Pfizer, Inc.—the world’s largest pharmaceutical company and second largest manufacturer of vaccines. Pfizer, which posted total revenues of $53.7 billion in 2018, announced Dr. Gottlieb’s election to the board on June 27, 2019.1 2 3 4 Dr. Gottlieb, […]

1 2 3 4